Molecular targeted functional, cellular and molecular imaging of atherosclerosis with antibody-conjugated superparamagnetic particles using magnetic resonance

R. Sharma, J. K. Katz, Yousef Haik, Ching J. Chen

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Background: Magnetic Resonance Imaging (MRI) is a powerful non-invasive technique that provides highresolution anatomical images of biological tissue based on their inherent physio-chemical properties. The signal from MRI can be modulated by contrast agents, which can be specifically directed to cells and molecules of interest, thereby providing an opportunity for targeted imaging. Aims: We propose to extend previous work that has used very high-resolution MRI to characterize atherosclerotic plaque in mice. Through targeted imaging of cells and molecules involved in mouse atherosclerosis, pathological processes and their response to interventions can be imaged in vivo. Aim 1 was to develop and refine gadoliniumapoferritin nano-particles that have shown great potential as relaxivity agents for MR contrast studies. Aim 2 was image antibody-conjugated iron-oxide micro-beads (0.9 μm)). Aim 3 was applied using these imaging strategies using high field strength MRI (11.7 T/21 T) to interrogate processes of inflammation and thrombosis in vascular models. Targeting can be accomplished with established and novel antibodies developed by phage display (against active forms of fibrin and glycoprotein IIbIIIa). Methods: Molecular imaging probes were synthesized and characterized in vitro. Arterial injury was associated with a sequence of molecular and cellular events that result in intimai hyperplasia and, in the apolipoprotein E-deficient mouse, results in accelerated atherosclerosis. Results: This model exhibited molecular imaging targets whose spatial and temporal expression was established. These features, in conjunction with straight, superficial course of the femoral artery makes it an ideal imaging target to examine the pathology of atherothrombosis noninvasively in vivo and to measure the effects of interventions. Conclusion: The approach of molecular imaging by using antibody-conjugated superparamagnetic contrast agents may provide unique opportunity of microimaging in clinical setup.

Original languageEnglish
Title of host publication2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
Pages464-466
Number of pages3
Volume1
Publication statusPublished - 2006
Externally publishedYes
Event2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings - Boston, MA, United States
Duration: 7 May 200611 May 2006

Other

Other2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
CountryUnited States
CityBoston, MA
Period7/5/0611/5/06

Fingerprint

Molecular imaging
Magnetic resonance
Antibodies
Imaging techniques
Glycoproteins
Molecules
Bacteriophages
Pathology
Iron oxides
Chemical properties
Display devices
Tissue
Magnetic Resonance Imaging

Keywords

  • Atherosclerosis
  • Contrast agents
  • Mice
  • Molecular imaging
  • MRI
  • Thrombosis

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Sharma, R., Katz, J. K., Haik, Y., & Chen, C. J. (2006). Molecular targeted functional, cellular and molecular imaging of atherosclerosis with antibody-conjugated superparamagnetic particles using magnetic resonance. In 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings (Vol. 1, pp. 464-466)

Molecular targeted functional, cellular and molecular imaging of atherosclerosis with antibody-conjugated superparamagnetic particles using magnetic resonance. / Sharma, R.; Katz, J. K.; Haik, Yousef; Chen, Ching J.

2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 1 2006. p. 464-466.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Sharma, R, Katz, JK, Haik, Y & Chen, CJ 2006, Molecular targeted functional, cellular and molecular imaging of atherosclerosis with antibody-conjugated superparamagnetic particles using magnetic resonance. in 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. vol. 1, pp. 464-466, 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings, Boston, MA, United States, 7/5/06.
Sharma R, Katz JK, Haik Y, Chen CJ. Molecular targeted functional, cellular and molecular imaging of atherosclerosis with antibody-conjugated superparamagnetic particles using magnetic resonance. In 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 1. 2006. p. 464-466
Sharma, R. ; Katz, J. K. ; Haik, Yousef ; Chen, Ching J. / Molecular targeted functional, cellular and molecular imaging of atherosclerosis with antibody-conjugated superparamagnetic particles using magnetic resonance. 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 1 2006. pp. 464-466
@inproceedings{0b852ae1274e49b68a9a4f2a7c262326,
title = "Molecular targeted functional, cellular and molecular imaging of atherosclerosis with antibody-conjugated superparamagnetic particles using magnetic resonance",
abstract = "Background: Magnetic Resonance Imaging (MRI) is a powerful non-invasive technique that provides highresolution anatomical images of biological tissue based on their inherent physio-chemical properties. The signal from MRI can be modulated by contrast agents, which can be specifically directed to cells and molecules of interest, thereby providing an opportunity for targeted imaging. Aims: We propose to extend previous work that has used very high-resolution MRI to characterize atherosclerotic plaque in mice. Through targeted imaging of cells and molecules involved in mouse atherosclerosis, pathological processes and their response to interventions can be imaged in vivo. Aim 1 was to develop and refine gadoliniumapoferritin nano-particles that have shown great potential as relaxivity agents for MR contrast studies. Aim 2 was image antibody-conjugated iron-oxide micro-beads (0.9 μm)). Aim 3 was applied using these imaging strategies using high field strength MRI (11.7 T/21 T) to interrogate processes of inflammation and thrombosis in vascular models. Targeting can be accomplished with established and novel antibodies developed by phage display (against active forms of fibrin and glycoprotein IIbIIIa). Methods: Molecular imaging probes were synthesized and characterized in vitro. Arterial injury was associated with a sequence of molecular and cellular events that result in intimai hyperplasia and, in the apolipoprotein E-deficient mouse, results in accelerated atherosclerosis. Results: This model exhibited molecular imaging targets whose spatial and temporal expression was established. These features, in conjunction with straight, superficial course of the femoral artery makes it an ideal imaging target to examine the pathology of atherothrombosis noninvasively in vivo and to measure the effects of interventions. Conclusion: The approach of molecular imaging by using antibody-conjugated superparamagnetic contrast agents may provide unique opportunity of microimaging in clinical setup.",
keywords = "Atherosclerosis, Contrast agents, Mice, Molecular imaging, MRI, Thrombosis",
author = "R. Sharma and Katz, {J. K.} and Yousef Haik and Chen, {Ching J.}",
year = "2006",
language = "English",
isbn = "0976798565",
volume = "1",
pages = "464--466",
booktitle = "2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings",

}

TY - GEN

T1 - Molecular targeted functional, cellular and molecular imaging of atherosclerosis with antibody-conjugated superparamagnetic particles using magnetic resonance

AU - Sharma, R.

AU - Katz, J. K.

AU - Haik, Yousef

AU - Chen, Ching J.

PY - 2006

Y1 - 2006

N2 - Background: Magnetic Resonance Imaging (MRI) is a powerful non-invasive technique that provides highresolution anatomical images of biological tissue based on their inherent physio-chemical properties. The signal from MRI can be modulated by contrast agents, which can be specifically directed to cells and molecules of interest, thereby providing an opportunity for targeted imaging. Aims: We propose to extend previous work that has used very high-resolution MRI to characterize atherosclerotic plaque in mice. Through targeted imaging of cells and molecules involved in mouse atherosclerosis, pathological processes and their response to interventions can be imaged in vivo. Aim 1 was to develop and refine gadoliniumapoferritin nano-particles that have shown great potential as relaxivity agents for MR contrast studies. Aim 2 was image antibody-conjugated iron-oxide micro-beads (0.9 μm)). Aim 3 was applied using these imaging strategies using high field strength MRI (11.7 T/21 T) to interrogate processes of inflammation and thrombosis in vascular models. Targeting can be accomplished with established and novel antibodies developed by phage display (against active forms of fibrin and glycoprotein IIbIIIa). Methods: Molecular imaging probes were synthesized and characterized in vitro. Arterial injury was associated with a sequence of molecular and cellular events that result in intimai hyperplasia and, in the apolipoprotein E-deficient mouse, results in accelerated atherosclerosis. Results: This model exhibited molecular imaging targets whose spatial and temporal expression was established. These features, in conjunction with straight, superficial course of the femoral artery makes it an ideal imaging target to examine the pathology of atherothrombosis noninvasively in vivo and to measure the effects of interventions. Conclusion: The approach of molecular imaging by using antibody-conjugated superparamagnetic contrast agents may provide unique opportunity of microimaging in clinical setup.

AB - Background: Magnetic Resonance Imaging (MRI) is a powerful non-invasive technique that provides highresolution anatomical images of biological tissue based on their inherent physio-chemical properties. The signal from MRI can be modulated by contrast agents, which can be specifically directed to cells and molecules of interest, thereby providing an opportunity for targeted imaging. Aims: We propose to extend previous work that has used very high-resolution MRI to characterize atherosclerotic plaque in mice. Through targeted imaging of cells and molecules involved in mouse atherosclerosis, pathological processes and their response to interventions can be imaged in vivo. Aim 1 was to develop and refine gadoliniumapoferritin nano-particles that have shown great potential as relaxivity agents for MR contrast studies. Aim 2 was image antibody-conjugated iron-oxide micro-beads (0.9 μm)). Aim 3 was applied using these imaging strategies using high field strength MRI (11.7 T/21 T) to interrogate processes of inflammation and thrombosis in vascular models. Targeting can be accomplished with established and novel antibodies developed by phage display (against active forms of fibrin and glycoprotein IIbIIIa). Methods: Molecular imaging probes were synthesized and characterized in vitro. Arterial injury was associated with a sequence of molecular and cellular events that result in intimai hyperplasia and, in the apolipoprotein E-deficient mouse, results in accelerated atherosclerosis. Results: This model exhibited molecular imaging targets whose spatial and temporal expression was established. These features, in conjunction with straight, superficial course of the femoral artery makes it an ideal imaging target to examine the pathology of atherothrombosis noninvasively in vivo and to measure the effects of interventions. Conclusion: The approach of molecular imaging by using antibody-conjugated superparamagnetic contrast agents may provide unique opportunity of microimaging in clinical setup.

KW - Atherosclerosis

KW - Contrast agents

KW - Mice

KW - Molecular imaging

KW - MRI

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=33845204269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845204269&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:33845204269

SN - 0976798565

SN - 9780976798569

VL - 1

SP - 464

EP - 466

BT - 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings

ER -